Companies / RetiSpec
AI analysis of hyperspectral retinal images to detect Alzheimer's disease pathology through an eye test.
retispec.com| Round | Date | Amount | Investors |
|---|---|---|---|
| Series A | Jul 26, 2024 | US$10M | iGan Partners (lead); Eli Lilly and Company, Topcon Healthcare, Gentex Corporation, Alzheimer's Drug Discovery Foundation Diagnostics Accelerator, Verge HealthTech Fund, Discovery Capital (University of Minnesota), Ontario Brain Institute, Centre for Aging + Brain Health Innovation. US$10M (C$13.8M) Series A announced Jul 26 2024 on PR Newswire; led by iGan Partners with new strategic investors Eli Lilly and Topcon Healthcare and returning Gentex, ADDF Diagnostics Accelerator, Verge HealthTech Fund, Discovery Capital, Ontario Brain Institute, CABHI and private investors; total raised US$17M |
Data as of September 26, 2026. Suggest a correction